Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
3.230
+0.360 (12.54%)
At close: Nov 16, 2026, 4:00 PM EST
3.141
-0.089 (-2.76%)
After-hours: Nov 16, 2026, 7:59 PM EST

Lexeo Therapeutics Statistics

Total Valuation

LXEO has a market cap or net worth of $267.39 million. The enterprise value is $78.86 million.

Market Cap267.39M
Enterprise Value 78.86M

Important Dates

The last earnings date was Monday, November 16, 2026, before market open.

Earnings Date Nov 16, 2026
Ex-Dividend Date n/a

Share Statistics

LXEO has 82.78 million shares outstanding. The number of shares has increased by 94.19% in one year.

Current Share Class 82.78M
Shares Outstanding 82.78M
Shares Change (YoY) +94.19%
Shares Change (QoQ) +3.57%
Owned by Insiders (%) 0.38%
Owned by Institutions (%) 86.26%
Float 49.78M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.23
P/TBV Ratio 1.23
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.69, with a Debt / Equity ratio of 0.03.

Current Ratio 8.69
Quick Ratio 8.32
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1,807.43

Financial Efficiency

Return on equity (ROE) is -62.39% and return on invested capital (ROIC) is -40.41%.

Return on Equity (ROE) -62.39%
Return on Assets (ROA) -36.71%
Return on Invested Capital (ROIC) -40.41%
Return on Capital Employed (ROCE) -51.68%
Weighted Average Cost of Capital (WACC) 13.04%
Revenue Per Employee n/a
Profits Per Employee -$1.67M
Employee Count68
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -64.27% in the last 52 weeks. The beta is 1.65, so LXEO's price volatility has been higher than the market average.

Beta (5Y) 1.65
52-Week Price Change -64.27%
50-Day Moving Average 3.35
200-Day Moving Average 4.97
Relative Strength Index (RSI) 53.38
Average Volume (20 Days) 2,977,773

Short Selling Information

The latest short interest is 17.04 million, so 20.58% of the outstanding shares have been sold short.

Short Interest 17.04M
Short Previous Month 17.55M
Short % of Shares Out 20.58%
Short % of Float 34.23%
Short Ratio (days to cover) 10.46

Income Statement

Revenue n/a
Gross Profit -85.44M
Operating Income -113.87M
Pretax Income -105.28M
Net Income -105.28M
EBITDA -113.24M
EBIT -113.87M
Earnings Per Share (EPS) -$1.27
Full Income Statement

Balance Sheet

The company has $194.78 million in cash and $6.25 million in debt, with a net cash position of $188.53 million or $2.28 per share.

Cash & Cash Equivalents 194.78M
Total Debt 6.25M
Net Cash 188.53M
Net Cash Per Share $2.28
Equity (Book Value) 216.69M
Book Value Per Share 2.62
Working Capital 181.34M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$87.38 million and capital expenditures -$340,000, giving a free cash flow of -$87.72 million.

Operating Cash Flow -87.38M
Capital Expenditures -340,000
Depreciation & Amortization 626,000
Net Borrowing -567,000
Free Cash Flow -87.72M
FCF Per Share -$1.06
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LXEO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -94.19%
Shareholder Yield -94.19%
Earnings Yield -39.25%
FCF Yield -32.81%

Analyst Forecast

The average price target for LXEO is $25.11, which is 677.40% higher than the current price. The consensus rating is "Strong Buy".

Price Target $25.11
Price Target Difference 677.40%
Analyst Consensus Strong Buy
Analyst Count 9
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2